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PROCEDURAL DUE PROCESS IMPLICATIONS OF
KENTUCKY'S THOROUGHBRED MEDICATION REGULATIONS
W. CHAPMAN HOPKINS*
INTRODUCTION
It is no secret that Kentucky's thoroughbred racing industry has
recently fallen on hard times. The past two years have been marked by
several nationally publicized tragedies including the death of Eight Belles at
the Kentucky Derby, allegations of steroid use by the three-year-old of the
year, Big Brown, and charges of medication abuse by the sport's most
successful trainer, Steve Asmussen. Needless to say, both those outside and
within the industry had ample reasons to call for a complete overhaul of
racing regulations.
Revision of the industry's medication regulation procedures has
undoubtedly been the number one issue on the thoroughbred horse racing
industry's agenda. Consequently, many organizations such as the NTRA,'
RMTC,2 KHRC,3 and TOBA,4 now find themselves scrambling to assemble
task forces aimed at reviewing and amending the thoroughbred racing
industry's medication policies. Each of these groups has inevitably found
itself looking for ways to demand accountability for illegal and improper
conduct on behalf of owners and trainers. These organizations seek to
impose heavy penalties for drug and medication violations that will be
swiftly and forcefully enforced.
In the industry-wide effort to penalize those found guilty of such
violations, it is important to remember that individuals who are charged are
entitled to certain constitutionally protected rights. Perhaps the most basic
of those rights is the entitlement to constitutional due process. Indeed, the
very regulations which prescribe penalties also demand that persons
charged with violations be afforded the right to a public hearing and the
* W. Chapman Hopkins is an associate with the Lexington office of McBrayer, McGinnis,
Leslie & Kirkland, PLLC. Mr. Hopkins received his BA in Finance from Transylvania University in
2006, and his Juris Doctorate from the University of Kentucky in 2009. Mr. Hopkins' practice areas
include litigation, equine and gaming law, and administrative law.
1 National Thoroughbred Racing Association
2 Racing Medication & Testing Consortium
3 Kentucky Horse Racing Commission. Note that in July 2008, Kentucky Governor Steve
Beshear signed an Executive Order replacing the Kentucky Horse Racing Authority with the Kentucky
Horse Racing Commission. However, because Kentucky's statutory texts and administrative regulations
have not yet been amended to reflect this change, for purposes of continuity, all references to the KHRA
and KHRC in this paper are one in the same.
4 Thoroughbred Owners and Breeders Association
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opportunity to defend their actions prior to the imposition of any penalty
that would affect their property rights.
Despite the existence of a facially constitutional hearing procedure,
a closer examination of the corresponding testing procedures prescribed by
the Kentucky Horse Racing Commission reveals that the current medication
testing process may contain so many flaws that it produces inaccurate
results. Consequently, the outcomes of public hearings, which are based
almost entirely on the test results, may not provide the defendant with
actual due process sufficient to meet constitutional guarantees.
This article will examine the extent to which improper and
potentially inaccurate testing procedures affect the constitutionality of
Kentucky's racing medication hearing process. Part I of this article will
examine the sources of due process protection and will analyze the current
administrative hearing process for violations of medication regulations.
Part II will then analyze the potential inadequacies of the current
medication testing procedures. Finally, Part III will explain the importance
of the Kentucky Horse Racing Commission's present efforts to amend these
deficiencies and provide a framework for resolving the due process
concerns.
I. THE RIGHT TO PROCEDURAL DUE PROCESS IN ADMINISTRATIVE
HEARINGS
The modern view of the right to procedural due process in
administrative hearings surfaced in the 1970's and is generally premised
upon the concept of fairness. The U.S. Supreme Court held in Goldberg v.
Kelly, 397 U.S. 254 (1970), that the Due Process Clause guarantees that
"'[t]he fundamental requisite of due process of law is the opportunity to be
heard' 5 through a hearing held "'at a meaningful time and in a meaningful
manner."
6
A. Origins of the Procedural Due Process Guarantee
The Goldberg Court detailed certain basic procedural steps that an
agency must take before it may deprive an individual of his property rights.
It explained that the Constitution requires the accused be given notice of the
proposed action, a meaningful opportunity to be heard, the ability to present
evidence, the right to cross examine adverse witnesses, and the chance to
confront the accusers in the presence of an unbiased decision maker. In
5 Goldberg v. Kelly, 397 U.S. 254, 267 (1970) (quoting Grannis v. Ordean, 234 U.S. 385,
394 (1914)).
6 Id. at 267 (citing Armstrong v. Manzo, 380 U.S. 545, 552 (1965)).
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addition, all of these procedures must be subject to judicial review.7 Most
importantly, however, the proceeding must be supported by "a finding of
fact [that is] based upon an evaluation of the evidence and conclusions
supported by substantial evidence. ''a Under Kentucky law, "[s]ubstantial
evidence is defined as evidence of substance and relevant consequence
having the fitness to induce conviction in the minds of reasonable
[persons]." 9
B. Procedural Due Process under Kentucky Law
State legislatures are entrusted with the duty of protecting
constitutional due process rights through statutory enactments. The
Kentucky legislature has codified these fundamental rights in Chapter 13B
of the Kentucky Revised Statutes (hereinafter "KRS"), which closely tracks
the rights afforded under the common law. Chapter 13B provides that:
(4) To the extent necessary for the full disclosure of all
relevant facts and issues, the hearing officer shall afford all
parties the opportunity to respond, present evidence and
argument, conduct cross-examination, and submit rebuttal
evidence, except as restricted by limited grant of
intervention or a prehearing order.'
KRS Chapter 13B also provides the parties with other basic procedural
rights, such as a hearing officer to preside over the hearing," "the
opportunity to file pleadings, motions, objections and offers of
settlement,"' 2 and the opportunity to be represented by counsel 3 .
Kentucky law is also similar to the common law with regard to its
relaxation of the evidentiary rules. Kentucky courts tend to take a broader
view of the admission of evidence in administrative hearings and generally
admit statements that would otherwise constitute hearsay if the statements
are "relevant and material."' 4 In other words, hearsay is admissible in an
administrative hearing as long as "it is the type of evidence that reasonable
See id. at 267-68.
Kaelin v. City of Louisville, 643 S.W.2d 590, 591 (Ky. 1982) (citing City of Louisville v.
McDonald, 470 S.W.2d 173, 177 (Ky. 1971)).
9 Allen v. Ky. Horse Racing Auth., 136 S.W.3d 54, 59 (Ky. Ct. App. 2004) (quoting Owens-
Coming Fiberglass Corp. v. Golightly, 976 S.W.2d 409,414 (Ky. 1998)).
'o KY. REV. STAT. ANN. § 13B.080(4) (West 2006).
" KY. REV. STAT. ANN. § 13B.080(l) (West 2006).
'2 KY. REV. STAT. ANN. § 13B.080(2) (West 2006).
13 Ky. REV. STAT. ANN. § 13B.080(5) (West 2006).
14 Wade v. Dept. of the Treasury, 840 S.W.2d 215, 218 (Ky. Ct. App. 1992) (citing Myers v.
Sec'y of Health and Human Servs., 893 F.2d 840, 846 (6th Cir. 1990).
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and prudent persons would rely on in their daily affairs."'" This flexibility
regarding the admission of evidence in administrative hearings is justified
by the Commonwealth's interest in the "reasonable exercise of its police
power,"'16 in addition to "the interests at stake and the costs of safeguarding
the accuracy of the tribunal's factual and legal determinations."' 7
C. The Statutory Mandate for Agency-Specific Due Process Guarantees
While KRS Chapter 13B sets forth Kentucky's general due process
procedures, administrative agencies are creatures of statute. Therefore, an
administrative agency's individual powers are more narrowly tailored by
the express terms of their respective enabling statutes.' 8  Because the
enabling statute is controlling, "the authority of the agency is limited to a
direct implementation of the functions assigned to the agency by the
statute." 19
KRS section 230.215, which governs horse racing in Kentucky,
vests sole administrative power in the Kentucky Horse Racing Commission
(hereinafter the "KHRC").20 The statute gives KHRA "forceful control of
horse racing in the Commonwealth with plenary power to promulgate
administrative regulations prescribing conditions under which all legitimate
horse racing and wagering thereon is conducted."'', The legislature granted
the KHRA the power to "regulate and maintain horse racing at race
meetings in the Commonwealth so as to dissipate any cloud of association
with the undesirable and maintain the appearance as well as the fact of
complete honesty and integrity of horse racing in the Commonwealth. 22
In addition to the broad authority granted to the KHRA under KRS
section 230.215, KRS section 230.240 enumerates several specific areas
over which the KHRA is obligated to exercise its rulemaking and
adjudicatory authority. The KHRA's obligations concerning medication
and drug use in the racing industry are set forth in KRS section 230.240(2).
The statue states in pertinent part:
The [KHRA] shall promulgate administrative regulations
for effectively preventing the use of improper devices, and
restricting or prohibiting the use and administration of
drugs or stimulants or other improper acts to horses prior to
" KY. REv. STAT. ANN. § 13B.090(1) (West 2006).
16 Smith v. O'Dea, 939 S.W.2d 353, 357 (Ky. Ct. App. 1997).
7id
18 See Pub. Serv. Comm'n v. Att'y Gen., 860 S.W.2d 296,298 (Ky. Ct. App. 1993).
19 Flying J Travel Plaza v. Dep't of Highways, 928 S.W.2d 344, 347 (Ky. 1996).20 See Ky. REV. STAT. ANN. § 230.215 (West 2006).
21 Ky. REv. STAT. ANN. § 230.215(2) (West 2006).
22 1d.
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the horse participating in a race. The [KHRA] may
acquire, operate, and maintain, or contract for the
maintenance and operation of, a testing laboratory and
related facilities, for the purpose of saliva, urine, or other
tests, and to purchase supplies and equipment for and in
connection with the laboratory or testing processes.23
D. The KHRA's Administrative Regulations
Pursuant to this statutory authorization, the KHRA enacted Title
810, Chapter One of the Kentucky Administrative Regulations, which sets
forth the "conditions under which all legitimate horse racing and wagering
thereon is conducted in the Commonwealth. 24 Within this chapter, sections
1:018, 1:028, and 1:029 relate specifically to medication testing procedures,
disciplinary procedures, and the hearing and review process, respectively.
It is necessary to examine each of these provisions in detail to determine
whether they conform to the constitutional requirements of due process.
(i) Medication Testing Procedures
Medication testing procedures and prohibited practices, for
thoroughbred racing in Kentucky, are set forth in 810 KAR 1:018. Section
Two, entitled "Use of Medication," states that a horse participating in any
race:
shall not carry in its body any drug, medication,
substance, or metabolic derivative, that:
(1) Is a narcotic;
(2) Could serve as an anesthetic or tranquilizer;
(3) Could stimulate, depress, or affect the circulatory,
respiratory, cardiovascular, musculoskeletal, or central
nervous system of a horse; or
(4) Might mask or screen the presence of a prohibited
drug, or prevent or delay testing procedures.25
23 Ky. REV. STAT. ANN. § 230.240(2) (West 2006).
24 810 Ky. ADMIN. REGS. 1:018 note (2009) (Historical).
25 810 Ky. ADMIN. REGS. 1:018(2)(2) (2009).
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Certain medications are deemed "therapeutic" and "necessary to improve or
protect the health of a horse" and are exempted from the restrictions.26
However, these medications must be administered by a licensed
veterinarian, and the dose cannot exceed an established threshold
concentration.27 Sections Four, Five, Six and Eight describe certain other
medications that are specifically exempted from regulatory restriction.2
The samples used for testing are to be acquired at a designated "test
bam" immediately following each race.29 According to the regulation, the
KHRA veterinarian shall take a sample from the winning horse of every
race as well as any horse the stewards designate.30  Notably, while the
veterinarian is responsible for determining the size of the sample to be
taken, the regulation lacks any specific guidance as to what constitutes a
sufficient sample size.31
Where the sample obtained is "greater than the minimum sample
requirement" as determined by the veterinarian, the remainder is stored
separately for use as a "split sample. 32 Where the sample taken is less than
the minimum sample requirement, no split of the sample is made, but one
can be requested by the owner or trainer.33 If a split sample is produced, it
is stored in a secured freezer in the test barn. 34 If the initial test results in a
positive finding, the trainer or owner may "request that [the] split sample
corresponding to the portion of the specimen tested by the commission
laboratory be sent" to a pre-approved laboratory for a second round of
testing.35 The regulation further demands that the process by which the
split sample is taken from the freezer and shipped to the secondary testing
laboratory be performed in compliance with strict chain of custody
procedures.36 As discussed below, the acquisition, storage, and testing of
the split sample is crucial to the due process evaluation because the sample
is often the only piece of evidence that the trainer can use to rebut a positive
test result.
Under this testing portion of the regulatory scheme, trainers are
deemed the absolute insurers of horses in their care in some jurisdictions.37
As a result, a rebuttable presumption of liability for any positive finding is
26 810 KY. ADM[N. REGS. 1:018(2)(1) (2009).
27 810 Ky. ADMIN. REGS. 1:018(2)(1)-(3) (2009).
28 810 KY. ADMIN. REGS. 1:018(2)(2) (2009).
29 See 810 Ky. ADMIN. REGS. 1:018(10), (11) (2009).
30 810 Ky. ADMIN. REGS. 1:018(11)(1) (2009).
31 810 Ky. ADMIN. REGS. 1:018(11)(2) (2009).
32 810 Ky. ADMIN. REGS. 1:018(1 1)(2)(b)-(c) (2009).
33 810 Ky. ADMIN. REGS. 1:018(11)(2)(a), (3)(a) (2009).
34 810 Ky. ADMIN. REGS. 1:01 8(12)(1)(b) (2009).
35 810 Ky. ADMIN. REGS. 1:018(12)(2)(a) (2009).
36 See 810 Ky. ADMIN. REGS. 1:018(13) (2009).
37 Bennett Liebman, The Trainer Responsibility Rule in Horse Racing, 7 VA. SPORTS & ENT.
L.J. 1, 21 (2007).
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placed solely on the trainer in Kentucky.38 Moreover, where a properly
acquired saliva, urine, or blood sample tests positive for a medication
violation, the positive result is "prima facie evidence that [the] horse was
administered and carried" a prohibited medication in violation of the
regulation. 39 Although this absolute insurer rule falls short of imposing
strict liability,40 the rebuttable presumption of guilt, combined with the
existence of sole liability, creates an exceedingly difficult, and sometimes
impossible, burden for the trainer to overcome.
(ii) Disciplinary Procedures
810 KAR 1:028 sets forth detailed disciplinary procedures and
penalties for medication violations. While it is not necessary to detail these
penalties for the purposes of this article, it is important to note that a trainer
is often stripped of his property interest, which implicates his due process
rights.
Further, 810 KAR 1:028 lists the types of medications for which
penalties may be imposed. Medications are broken down by class, with
Class A medication violations being the most heavily penalized and Class
D violations generating the least serious punishment. 41 The severity of the
penalties is tiered according to whether the violation is a trainer's first,
second, or third offense.42 Penalties may be enforced against the trainer as
well as the horse and can include suspension or revocation of a trainer's
license, suspension of the horse from racing, and monetary fines ranging
from $500 to $50,000.
4 3
(iii) Hearing and Review Process
Upon a finding of a positive test result, and before the KHRA
imposes any penalty, the positive test result is reviewed at a stewards'
hearing.44 Prior to the hearing, the party charged with the violation must
receive written notice.45 Furthermore, the hearing must occur within 14
days after service of the notice.46 The hearing is not subject to any
technical rules of procedure or evidence47; however, all testimony must be
given under oath, and the stewards are required to generate a record of the
38 810 KY. ADMIN. REGS. 1:018(15)(2) (2009).
39 810 KY. ADMIN. REGS. 1:018(2)(5) (2009).
4o Liebman, supra note 37, at 21.
41 See 810 Ky. ADMIN. REGS. 1:028(4) (2009).
42 Id.
43 Id.
"See 810 KY. ADMIN. REGS. 1:029(2) (2009).
45 810 KY. ADMIN. REGS. 1:029(2)(1) (2009).
46 810 KY. ADMIN. REGS. 1:029(11)(7) (2009).
47 810 KY. ADMIN. REGS. 1:029(2)(4) (2009).
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hearing.48 If a violation is found, the stewards must issue a written ruling
that includes a description of the regulation in question and an appropriate
penalty.49
Any party found to be in violation of the medication regulations
may request a hearing within ten days of the stewards' ruling by filing a
written appeal with the KHRAi" Prior to this hearing, parties must receive
notice that includes a "clear and concise factual statement sufficient to
inform each party with reasonable definiteness of the type of acts or
practices alleged to be in violation of the statute or administrative
regulations promulgated thereunder." 5' Once the hearing begins, the parties
can conduct discovery, issue subpoenas, and utilize all of the pretrial
procedures afforded by the Kentucky Rules of Civil Procedure.52
A stewards' hearing is similar to a civil or criminal trial and once it
begins, the parties may be "represented by counsel,"53 "respond and present
evidence and argument on all issues involved,"54 and "examine authority
memoranda and data and all other information which is or has been
considered by the commission in investigating and hearing the matter or
which may be offered as evidence."5 5 All parties are permitted to subpoena
and cross-examine witnesses as needed and may introduce any evidence
they choose. 6 However, ex parte communications are prohibited for the
duration of the hearing. 57 Furthermore, the KHRA will usually request that
the Attorney General appoint a "special prosecutor" to argue against the
accused because of the adversarial nature of the hearing.
5 8
At the conclusion of the hearing, the KHRA "[t]ake[s] the matter
under advisement" and issues a prompt decision.59 The final ruling
includes a statement of findings of fact and law,60 the violated statute or
administrative regulation, 61 "[a] separate statement of reasons for the
decision[ ],62 and a corresponding penalty.63 The KHRA's final decision
may be appealed to the Franklin Circuit Court within ten days.64 If the
48 810 KY. ADMIN. REGS. 1:029(2)(5) (2009).
49 8 10 KY. ADMIN. REGS. 1 :029(2)(6) (2009).
50 810 Ky. ADMIN. REGS. 1:029(2)(10) (2009).
51 810 KY. ADMIN. REGS. 1:029(3)(1)(d) (2009).
52 810 KY. ADMIN. REGS. 1:029(3)(2) (2009).
53 810 KY. ADMIN. REGS. 1:029(4)(2)(a) (2009).
54 810 Ky. ADmiN. REGs. 1:029(4)(2)(b) (2009).
55 810 KY. ADMIN. REGS. 1:029(4)(2)(c) (2009).
56 810 KY. ADMIN. REGS. 1:029(4)(2)(b), (4) (2009).
57 810 KY. ADMIN. REGS. 1:029(4)(7)(b) (2009).
58 810 KY. ADMIN. REGS. 1:029(4)(1) (2009).
59 810 KY. ADMIN. REGS. 1:029(4)(9)(a)-(b) (2009).
60 810 KY. ADMIN. REGS. 1:029(4)(10)(d)-(e) (2009).
61 810 KY. ADMIN. REGS. 1:029(4)(10)(c) (2009).
62 810 KY. ADMIN. REGS. 1:029(4)(10)(f) (2009).
63 810 Ky. ADMIN. REGS. 1:029(4)(10)(g) (2009).
64 810 KY. ADMIN. REGS. 1:029(5) (2009).
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appeal is granted, the case proceeds through the court system like any other
judicial proceeding.65
II. DOES THE KHRA's ADMINISTRATIVE PROCESS COMPORT WITH
PROCEDURAL DUE PROCESS GUARANTEES?
As discussed above, common law due process guarantees an
individual the right to a hearing before any type of penalty is assessed that
might affect his or her property rights.66 More specifically, the right to
procedural due process requires notice, the opportunity to be heard, and the
chance to examine witnesses and confront the accuser.67 Most importantly,
the accusations and proceedings must be based on substantial and credible
evidence, which must be accompanied by a valid finding of fact.68
A. Constitutionally Sufficient Hearing and Review
An examination of the procedural provisions set forth by Kentucky
statutes and the KHRA administrative regulations reveal, at least facially,
that the provisions comply with due process requirements required by the
U.S. Constitution. As specifically provided by KRS section 230.240 and
810 KAR 1:029, persons accused of medication violations in the
thoroughbred racing industry are afforded a wealth of procedural
protections prior to the imposition of any penalty that would affect his or
her property rights. For example, the accused is given ample notice and is
afforded the right to a hearing prior to imposition of any penalty. 69 At the
authority hearing, the accused may face his accuser, present and cross
examine-witnesses, and offer rebuttal evidence.7 °
At first glance, these procedural protections appear to afford the
accused with the full panoply of constitutionally required due process
rights. However, a closer review of the medication testing procedures
reveals a number of potentially troublesome deficiencies in both the testing
process and the acquisition of samples on which those tests are based. As a
result, the evidence produced by these testing procedures may be inaccurate
or untrustworthy. Considering that these test results are often the sole
evidence utilized in reaching a verdict, any doubt as to their substance or
credibility may greatly reduce or destroy the constitutionality of the
65 See id.
66See Goldberg v. Kelly, 397 U.S. 254, 267-68 (1970).
67 Id. at 267-71; See also Franklin v. Natural Res. and Envtl. Prot. Cabinet, 799 S.W.2d 1, 5
(Ky. 1990).
6 See Kaelin v. City of Louisville, 643 S.W.2d 590, 591 (Ky. 1982).69 See 810 KY. ADMIN. REGS. 1:029(2) (2009).
70 810 KY. ADMiN. REGS. 1:029(4)(4) (2009).
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otherwise procedurally valid hearing and can impair the entire
administrative process.
B. Evidentiary Deficiencies
Where the methods for the acquisition and testing of evidence
underlying the administrative hearing are found to be inaccurate or
insubstantial, the validity and trustworthiness of the evidence submitted is
necessarily reduced. Consequently, any use of such inaccurate evidentiary
findings as the basis for a conviction would open the door for a reversal of
the initial decision. Moreover, even where the positive initial finding is
deemed accurate, the absence of access to credible rebuttal evidence would
not enable an accused to properly defend the action in accordance with his
constitutional rights.
Despite the facially adequate process provided by the KHRA, the
corresponding medication testing and analysis procedures prescribed by
810 KAR 1:018 possess certain deficiencies that may impair the
administrative process. The greatest cause for concern revolves around the
split sample requirements as well as the testing standards and procedures.
As discussed below, deficiencies in these regulations make it possible for
trainers to challenge the results of medication hearings, which in turn makes
it possible for a court to rule that the entire administrative process is
unconstitutional.
(i) Split Sample Requirements
From a trainer's point of view, the most important protection
provided by the hearing process is the opportunity to present rebuttal
evidence that contradicts the KHRA's positive findings. In medication
disputes, the result of a proceeding most often turns entirely on the validity
of the positive test result presented by the KHRA.
a. Examining the KHRA's Approach
One of the only means by which a trainer can rebut a positive
finding by the KHRA is to introduce contradictory test results from a split
sample at the hearing. Appropriately, the acquisition of split samples is
possible each time a horse is tested under 810 KAR 1:018. 71 According to
the regulatory language, any split sample acquired is to be preserved so as
to provide a trainer with an opportunity to submit it as rebuttal evidence.72
71 See 810 Ky. ADmIN. REGS. 1:018(11) (2009).
7 See 810 KY. ADMIN. REGS. 1:018(12) (2009).
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However, the language of the regulation wholly fails to explicitly demand
that a split sample be taken in every instance. Rather, the language of 1:018
merely states that the size of the sample is within the discretion of the
veterinarian taking the sample.73
Not only does the regulation not demand that a sample be taken in
every instance, but it provides no guidance for the KHRA veterinarian to
follow in determining what constitutes an adequate sample size. The
regulation only requires a split sample when the sample is larger than the
"minimum sample requirement" (which, again, is determined by the
discretion of the vet).74 Thus, if the sample taken by the veterinarian does
not meet or exceed the minimum sample size, then no split sample is
produced.75 A trainer is without any effective rebuttal evidence when there
is no split sample for a second round of testing and consequently has very
little chance of overcoming any positive finding by the KHRA.
b. Mitigation Through Trainer Request
There is only one protective mechanism for trainers in 810 KAR
1:018. The regulation states that "an owner or trainer may request that a
split sample be taken from a horse he owns or trains by the [KHRA]
veterinarian. 7 6 This provision serves as a "catch all" that can be used to
ensure the production of a split sample. Understandably, it appears as
though the KHRC inserted this language as a means of protecting itself by
shifting ultimate responsibility to the trainers in ensuring that a split sample
is taken. Moreover, a trainer who fails to request a split sample is legally
estopped from later arguing that the absence of a sample denied him due
process since he had the last clear chance to avail himself of the protection.
Thus, it appears that 810 KAR 1:018(10)(3) serves to mitigate, if not
completely cure, any deficiency in the regulations' split sample provisions.
Several common scenarios illustrate that a trainer's option to
request this split sample may not always fully protect him. Indeed, these
situations demonstrate that even though a trainer has the authority to
request a split sample, certain factors beyond his control may make the
provision so inadequate that the mitigating effect of the sample is
destroyed. For purposes of analyzing these scenarios, it may be helpful to
envision a hypothetical trainer, John Doe, and his prized three-year old,
RunForTheRoses. In these hypotheticals, assume that trainer Doe is a
highly successful, and immensely popular, trainer who has 100 horses in
training. Further, as is often the case, assume that the size of Doe's
73 810 KY. ADMIN. REGS. 1:018(11)(2) (2009).
74 id.
75 See 810 KY. ADMIN. REGS. 1:018( 11)(2)(a) (2009).
76 810 KY. ADMIN. REGS. 1:018(1 1)(3) (2009) (emphasis added).
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operation requires him to employ multiple groomsmen, caretakers, and
assistant trainers, and that he has stables at several racetracks around the
country.
First, it is often unclear whether trainers are fully aware of their
right to request a split sample. Even though the statute affords trainers this
right, there is no guarantee that every trainer has been put on notice or has
taken time to adequately research his legal rights. If trainer Doe is like
most trainers, he has little or no legal background. Additionally, the fact
that trainer Doe has multiple horses running on any given day makes it
unlikely that he has the time or ability to be physically present at the test
barn after each race. As discussed above, the regulations do not require that
a split sample be taken without a request from trainer Doe. Thus, trainer
Doe's absence in the test barn, while justifiable, leaves him potentially
defenseless if the test yields a positive result.
Second, even if a trainer is aware of his right to a split sample, he
may intentionally decline to make such a request. Even if he does request a
split sample following the race, he may still decline to have it tested. In our
hypothetical, trainer Doe may decline the additional sample if he knows
that he has not administered any illegal medications to RunForTheRoses.
In other words, he may not consider the split sample necessary. However,
if one of his many assistant trainers or employees administered illegal
medications to the horse without trainer Doe's knowledge, or if the test was
skewed by some other naturally occurring phenomenon, he would be left
without any means to rebut a positive finding.
In this scenario, the likelihood that trainer Doe will request a split
sample is decreased by the fact that the regulation requires him to pay the
testing and sample-shipping costs himself.77 Since a prominent trainer such
as Doe can have upwards of one hundred horses in training at any given
time, the collective testing and shipping costs for his stable may amount to
more than the fine that the regulation permits him to pay to mitigate the
positive result. Thus, the cost of gathering the evidence necessary to defend
the charge and the opportunity cost of attending the hearing may deter
trainers such as Doe from ever attempting to combat most positive results,
especially when the regulation permits them to simply pay the mitigating
fine and move on. As a result, a colorable argument can be made that the
current structure of the regulations discourages trainers from utilizing the
regulations' procedural protections to such an extent that the otherwise
facially appropriate regulations are, in practical effect, inadequate.
A third situation may arise where, even though the trainer requests
that a split sample be taken, the horse simply does not, or cannot, produce
enough blood, saliva, or urine to create the sample. According to Dr.
77 810 Ky. ADMIN. REGS. 1:018(11X4) (2006).
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Thomas Tobin, a renowned large-animal veterinarian and toxicologist, it is
not uncommon for horses to act fractious when having their blood drawn or
to simply be unable or unwilling to provide sufficient amounts of saliva or
urine to produce two samples.78 In our hypothetical, the inability of the
veterinarian to acquire sufficient blood, saliva, or urine from
RunForTheRoses would leave trainer Doe without a split sample despite his
request for the sample. If RunForTheRoses' single sample tested positive
for a medication violation, trainer Doe would be unable to provide any
direct rebuttal evidence to submit at the hearing. When combined with the
presumption of guilt, this lack of rebuttal evidence would essentially place
strict liability on trainer Doe, and any ensuing hearing would be more of a
formality rather than a constitutionally-afforded opportunity to prove his
innocence.
c. Examining an Alternative Approach
The deficiencies in the acquisition and testing of split samples are
made more apparent by comparing the process to the way in which other
equine regulatory bodies, such as the United States Equestrian Federation
(hereinafter "USEF"), handle similar testing. The USEF is a governing
body that presides over almost all non-racing related equine activities, and
it has promulgated a full set of rules that all participants must follow.
Subchapter 4 of USEF General Rules (hereinafter "GR") addresses
drugs and medications and sets forth the procedure for the acquisition and
testing of blood samples. Similar to the KHRA, the USEF requires that the
tubes be divided into two samples "upon the collection of a sufficient
number of tubes of' blood or urine.79 Like the KHRA, one tube is to be
used for testing, and the second tube is to be maintained as a split sample
available for use by the trainer as rebuttal evidence.80 However, the USEF
takes added measures to ensure that a second sample is acquired in every
situation by requiring that a second tube be produced even when the trainer
is not present or fails to request that one be made.8' The USEF also
demands that blood, urine, and saliva samples each be tested. In addition,
the USEF directs that the horse be administered furosemide in a timely
fashion to ensure that enough urine is produced for a second sample if
necessary.8 2 Although the KHRA also permits the use of ftrosemide, it
does so only in relation to pre-race necessity rather than as a means of
78 Interview with Dr. Thomas Tobin, Veterinarian and Pharmacologist, in Lexington, Ky.
(Mar. 17, 2009).
79 U. S. EQUESTRiAN FED'N, USEF RULE BOOK Gen. Rule 402(4), at GR46 (2009),
http://www.usef.org//documents/ruleBook/2009/03-general%20rules.pdf.
'o See id. Gen. Rule 402,405-06, at GR45-50.
" id. Gen. Rule 402(4), at GR 46.
82 Id. Gen. Rule 405(3), at GR 47.
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ensuring the acquisition of adequate urine samples.83 Further, in the event
that a split sample cannot be obtained, any portion of the original sample
not used in the initial test must be used as the split sample and tested
again.84
As evidenced by these provisions, the USEF makes a more
concerted effort to ensure the procurement and analysis of split samples
each time a collection is made. As opposed to the KHRA, the USEF places
full responsibility on itself, rather than the trainer, to guarantee that a
second sample is acquired whenever possible. The USEF proactively
addresses the situation where a horse is unwilling or unable to produce a
large enough sample. Additionally, the USEF provides a fall-back remedy
that allows any remaining portion of the original sample to be used as a
split sample.
These acts go a step beyond those prescribed by the KHRA and
help to ensure that a split sample is acquired. More importantly, these
provisions demonstrate the USEF's awareness of the importance of
providing an accused trainer with the opportunity to acquire the rebuttal
evidence necessary to provide a constitutionally valid hearing.
(ii) Testing Procedures
Due process requires that an administrative hearing be based on
valid findings of fact and presentation of evidence that is both substantial
and accurate.85 Without these guarantees, the result of the hearing, even
though procedurally sufficient, would lack a proper factual and evidentiary
basis that would run the risk of being overturned upon review.
Under the KHRA regulations, a "positive finding" occurs when the
"[KHRA] laboratory has conducted testing and determined that a drug,
medication, or substance, the use of which is restricted or prohibited by
[the] administrative regulation, was present in the sample. 86 Even though
evidentiary standards are not strictly enforced in administrative
proceedings,87 the evidence upon which a positive finding is based must be
sufficiently substantial to "induce conviction in the minds of reasonable
[persons]. ' '88 Although hearsay evidence is permitted, such evidence "shall
not be sufficient in itself to support an agency's findings of fact unless it
83 See 810 Ky. ADMIN. REGS. 1:018(6) (2009).
4 U. S. EQUESTRIAN FED'N, supra note 82, Gen. Rule 406(7), at GR 47.
85 See Allen v. Ky. Horse Racing Auth., 136 S.W.3d 54, 59 (Ky. Ct. App. 2004) (citing
Owens-Coming Fiberglass Corp. v. Golightly, 976 S.W.2d 409,414 (Ky. 1998)).
16 810 KY. ADMIN. REGS. 1:018(1)(6) (2009).
17 See Wade v. Dept. of the Treasury, 840 S.W.2d 215, 218 (Ky. Ct. App. 1992).
88 Allen v. Ky. Horse Racing Auth., 136 S.W.3d 54, 59 (Ky. Ct. App. 2004) (quoting Owens-
Coming Fiberglass Corp. v. Golightly, 976 S.W.2d 409,414 (Ky. 1998)).
[Vol. 2 No. I
2009-2010] KY THOROUGHBRED MEDICATION REGULATIONS 41
would be admissible over objections in civil actions"89 and is accompanied
by additional "competent evidence which by itself would have been legally
sufficient to support the findings." 90
As previously mentioned, the KHRA's regulations provide for the
testing of blood and urine samples for all winning horses, as well as all
others required by the stewards. 91 The regulations set forth the method of
sample procurement and prescribe the classification of medicines whose
presence would result in a violation.9 2 However, the absence of certain
standardization threshold provisions may diminish the accuracy and validity
of these medication testing procedures. Specifically, the regulations fail to
establish: (1) standardized testing procedures and quality assurance
standards and (2) medication threshold levels that are sufficiently detailed.
a. Standardized Testing Procedures
The text of the KHRA regulations is wholly devoid of any language
setting forth standardized testing procedures or quality control mechanisms
that the KHRA laboratory is required to follow. Thus, the testing
procedures and quality control mechanisms utilized in the testing of the
samples are determined solely by the discretion of this laboratory.
Currently, Kentucky has no facility that is capable of analyzing
blood, saliva, or urine samples. Therefore, the KHRA has been forced to
contract with out-of-state laboratories to perform medication tests.93
According to a recent report produced by the KHRA, that was presented to
Kentucky Governor Steve Beshear, there are currently eighteen laboratories
in the U.S. that are capable of performing these tests.94 Of those eighteen
laboratories, only two are for-profit and the remaining sixteen labs are
affiliated with colleges and universities. 95 Strikingly, only four of the
eighteen labs are quality control certified.96
Through December 2008, the KHRA contracted with the Iowa
Racing Chemistry Veterinary Diagnostics Lab located at Iowa State
University to perform these tests. Iowa State was the sole laboratory used
by the KHRA, which means that it tested every sample taken from a
racehorse in Kentucky. Iowa State's lab is not quality control certified
89 KY. REV. STAT. ANN § 13B.090(1) (West 2006).
90 Big Sandy Cmty. Action Program v. Chaffins, 502 S.W.2d 526, 530 (Ky. 1973).
91 810 KY. ADMIN. REGS. 1:018(11)(1) (2009).
92 See 810 KY. ADMIN. REGS. 1:018 (2009).
93 See KENTUCKY HORSE RACING COMMISSION, REPORT OF THE GOVERNOR'S TASK FORCE
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which greatly increased the likelihood of inaccurate test results.9 7
Recognizing this potential problem, the KHRC terminated its relationship
with Iowa State in January 2009 and entered into a contract with the
University of Florida, which has received the highest level of standardized
testing and quality assurance accreditation.
Unfortunately, this contract with Florida does not provide a full
guarantee that the test results will remain subject to sufficient quality
control standards in the future. As noted by the KHRC in its report to
Governor Beshear, acquiring and maintaining accreditation is a costly
endeavor and "financial problems for state governments and universities
directly and adversely impact funding for the university-affiliated
laboratories' operating budgets." 98 Thus, Florida's testing facility, a state-
owned and operated entity, is particularly vulnerable to economic
downturns that may decrease its funding. Any decrease in funding may
cause a reduction in quality assurance that would potentially render the test
results inaccurate, or at the very least, unreliable in the minds of a
reasonable person.
b. Regulatory Threshold Requirements
The presence of certain drugs, medications, and other substances in
a horse's sample will result in a positive finding in violation of the KHRA's
administrative regulations.99 These substances can be broken down into
two categories: (1) therapeutic (those medications necessary to improve or
protect the health of a horse) and (2) non-therapeutic (those medications
that do not provide health related benefits). The presence of any level of
non-therapeutic medication in a horse's sample, other than minimal levels
of certain naturally occurring substances, will result in a positive finding. 00
This policy is both fair and necessary, as these substances can unfairly
enhance a horse's performance and, potentially, endanger the horse's long-
term health.
Therapeutic medications, however, are permitted as long as they do
not exceed specific threshold concentrations.'01 These thresholds are most
commonly defined by the variable concentration levels of the therapeutic
substance within a given sample. 10 2 The reason for this distinction is that
below these threshold levels, therapeutic medications are not believed to
9' See id at 38.
9
' Id. at33.
99 See 810 Ky. ADMIN. REGS. 1:018(1X6) (2009).100 See 810 KY. ADMiN. REGS. 1:018(1)(6), (2) (2009).
101 810 Ky. ADMIN. REGS. 1:018(2)(3) (2009).
102 See Wendy Spencer et. al., Review of the Current Status of Thresholds/Withdrawal Time
Guidelines for Therapeutic Medications in Performance Horses, 54 AAEP PROCEEDINGS 29,33 (2008),
http://www.cabi.org/vetmedresource/FullTextPDF/2009/20093131466.pdf.
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affect equine physiological systems and, as a result, have no direct
influence on a horse's performance or health.
10 3
This variable concentration level forms the basis for medication
regulation by providing the legally permissible presence of the therapeutic
substances.' 4  The KHRA establishes a specific list of permitted
therapeutic medications along with their corresponding threshold
concentration levels.105 Despite the implementation of this seemingly well-
defined system of therapeutic medication regulations, the KHRA's system
is not without fault.
To date, there has been no across-the-aboard adoption of a uniform
set of threshold requirements by the racing industry, despite a recognition
as far back as 1995 that the appropriate concentration levels should be
identified "'so as not to lead to disciplinary action based on
pharmacologically insignificant traces of these substances."", 0 6 While the
KHRA regulations, which follow the guidelines proposed by the Racing
Medication and Testing Consortium ("RMTC"), allow minimal levels of
eleven therapeutic medications, the American Association of Equine
Practitioners currently recognizes at least fifty acceptable therapeutic
medications. 10 7 Consequently, the KHRA regulations impose penalties for
the presence of more than forty medications that have been proven to have
no pharmacological effect on a horse. This penalty for the presence of this
type of medication appears to constitute an unconstitutional deprivation of
rights.
However, for those medications the KHRA currently allows, proper
concentrations are not always easily administered. First, the medications'
highly technical scientific form creates implementation problems for
trainers. "[A] regulatory threshold, expressed as a concentration in plasma
or urine, is not a particularly useful piece of information to horsemen and
veterinarians, who need explicit guidelines as to when to withdraw a
medication to avoid exceeding the regulatory threshold."'' 0 8 Hence, trainers
may not have the practical ability to take advantage of what little leeway
the KHRA provides.
In addition, there is substantial evidence that the threshold levels
used by the RMTC and the KHRA may be set inappropriately low, thereby
making them unnecessarily vulnerable to inaccuracies caused solely by
statistical error. Because of numerous variables, such as an individual
horse's metabolic rate, interaction with other medications, and other
103 See id. at 33-35.
'04 Id. at 36.
105 810 Ky. ADMIN. REGS. 1:018 (4)-(6), (8) (2009).
106 Wendy Spencer, supra note 105, at 30.
107 See id. at 30-33.
'
0
' ld. at 35.
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"unique aspects of the animal's physiology," there is a significant statistical
probability that any given test will produce a positive finding, even if the
medication was properly administered.' 9
Take, for example, furosemide, for which the KHRA formerly set
thirty nanograms per milliliter (30-ng/ml) as the appropriate threshold." °
Based on that threshold, a study found that there was a 1:1000 probability
that scientific error would cause the presence of an overage."' This
number may seem small, but considering that Kentucky produces over
10,000 samples per year, that percentage equates to at least ten innocent
trainers being found in violation of the regulations each year. 1 2 As a result
of this statistical deficiency, the RMTC and KHRA increased the regulatory
threshold of furosemide to 100-ng/ml. 1 3 No similar analysis has been
performed on other permitted therapeutic substances, leaving open the
possibility that numerous positive test results for these substances may
actually be the result of statistical overages, not trainer misconduct
c. Fine and Suspension
The construction of 810 KAR 1:028 permits the imposition of fines
and/or suspensions for a violation and, in some cases, permits the payment
of a fine to mitigate the level of suspension imposed on a trainer. This
construction raises the potentially serious constitutional issue of whether
the Act permits the KHRA to engage in an abuse of agency discretion in
choosing what combination of penalties to impose.
The language of 810 KAR 1:028 gives a great deal of discretion to
the KHRA in determining whether, and to what extent, to impose a
combination of monetary fines and suspensions on a trainer whose horse
tests positive for an illegal substance. 14 As a result, an inherent risk exists
that any determination by the Agency could be found arbitrary and
capricious and, thus violative of constitutional due process. Under general
constitutional law, state legislatures are permitted to establish standards of
legal conduct under which an agency may operate." 5  As long as that
delegation of discretionary power is guided by an "intelligible principle" of







114 See 810 Ky. ADMIN. REGS. 1:028(4) (2009).
115 See Citizens to Protect Overton Park v. Volpe, 401 U.S. 402 (1971); see also Motor
Vehicle Mfrs. Ass'n of the United States v. State Farm Mut. Auto. Ins. Co., 463 U.S. 29 (1983).
116 Whitman v. American Trucking Ass'ns., Inc., 531 U.S. 457, 474 (2001).
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The Kentucky state legislature has delegated discretionary authority
to the KHRA under KRS section 230.215. The statute gives the KHRA
"plenary power to promulgate administrative regulations prescribing
conditions under which all legitimate horse racing and wagering thereon is
conducted."' 17 This language serves as an intelligible principle in which
the KHRA is permitted to exercise its own discretion in enacting more
specific regulations, such as 810 KAR 1:028.
Despite this grant of authority, general constitutional law prohibits
agencies like the KHRA from enacting any regulation that would permit an
arbitrary and capricious determination, even if the agency is guided by a
valid intelligible principle. 18 Even though 810 KAR 1:028 establishes
general ranges of monetary penalties and suspension periods based on the
violation, the regulation fails to set forth specific, narrowly-drawn penalties
that correspond to specific violations. Moreover, the decision of whether to
permit the payment of fines to mitigate certain suspension periods is left up
to the "agreement" reached by the trainer and the KHRA. Even then the
parties' agreement may consist of a combination of monetary fines,
forfeiture of purse money, or both." 9 Ultimately one would have to assume
that, due to the discrepancy in bargaining position between the KHRA and
the trainer, and the trainer's need to make a quick return to active duty, the
"agreement" reached by the parties would be less of a negotiation and more
of a unilateral decision by the KHRA.
As mentioned above, an arbitrary and capricious standard of review
is used to determine whether the KHRA's ultimate decision is
unconstitutional. 20  Under this standard, the KHRA "must examine the
relevant data and articulate a satisfactory explanation for its action
including a 'rational connection between the facts found and the choice
made."",12' Additional factors to consider include whether: (1) the agency
relied on factors the legislature would not have intended it to consider, (2)
the agency entirely failed to consider one or more important aspects of the
case, (3) the agency's decision ran counter to the facts before it, and (4) the
result was so implausible that it could be ascribed only to the product of
agency bias. 1
22
..7 KY. REV. STAT. ANN. § 230.215(2) (West 2006).
118 See Citizens to Protect Overton Park, 401 U.S. at 414.
119 810 Ky. ADMIN. REGs. 1:028(4) (2006).
120 See Citizens to Protect Overton Park, 401 U.S. at 414.
121 Motor Vehicle Mfrs. Ass'n of the United States v. State Farm Mut. Auto. Ins. Co., 463
U.S. 29,43 (1983) (quoting Burlington Truck Lines v. United States, 371 U.S. 156, 168 (1962)).
2 1Id. at43.
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III. CONCLUSION AND RECOMMENDATION
Without question, the current state of thoroughbred racing
necessitates an industry-wide effort to strengthen medication restrictions
and penalties. Regardless of the need to impose penalties, any effort to
tighten medication reform must be done in compliance with basic
constitutional rights. While the recently revised Kentucky Horse Racing
Authority's administrative regulations provide facially appropriate hearing
procedures, certain deficiencies within the regulations' testing procedures
may potentially impair the evidence on which those procedures are based,
thereby reducing or destroying their constitutionality.
The most striking deficiencies relate to the acquisition and analysis
of blood, urine, and saliva samples. Specifically, deficiencies in the
language regarding the production of split samples, the standardization of
testing procedures and quality control mechanisms, and the creation of
scientifically sufficient threshold requirements present problems that may
diminish the credibility of the evidence on which the administrative process
is based.
Fortunately, each of these problems can be cured through simple
changes in the language of the regulations. Many of these issues have
already been noted by the KHRC and efforts are underway to institute the
necessary revisions. For example, the KHRC has initiated action to join
with the RMTC in developing standardized testing procedures, and it has
informed Kentucky Governor Beshear of the need to implement these
standardized testing procedures. Additionally, the KHRC has begun
campaigning for the creation of a centralized testing facility within the state
of Kentucky that would adhere to the strictest quality control standards.
Moreover, the KHRC remains receptive to advice from the Association of
Equine Practitioners and other industry experts concerning the measures it
can take to increase the number of permissible therapeutic medications and
other recommended changes in the corresponding medication threshold
levels.
However, a mere discussion of these changes is not enough. In
order to fully comply with the demands of constitutional due process, the
KHRC must take affirmative steps to revise the language of its
administrative regulations to reflect these changes. Further, the KHRC
must ensure that its officers comply with each and every element of the
regulations; otherwise, the KHRC runs the risk that its otherwise facially
constitutional hearing procedure may be destroyed by an insufficient
evidentiary basis. If, however, these changes are effectuated by the KHRC
and adhered to by its officers, the effectiveness and overall constitutionality
of these regulations will be greatly increased, and they will withstand the
highest level ofjudicial scrutiny.
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